387 related articles for article (PubMed ID: 19321980)
1. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients.
Bolignano D; Lacquaniti A; Coppolino G; Donato V; Fazio MR; Nicocia G; Buemi M
Kidney Blood Press Res; 2009; 32(2):91-8. PubMed ID: 19321980
[TBL] [Abstract][Full Text] [Related]
2. "Normoalbuminuric" diabetic nephropathy: tubular damage and NGAL.
Lacquaniti A; Donato V; Pintaudi B; Di Vieste G; Chirico V; Buemi A; Di Benedetto A; Arena A; Buemi M
Acta Diabetol; 2013 Dec; 50(6):935-42. PubMed ID: 23754672
[TBL] [Abstract][Full Text] [Related]
3. Detection of an earlier tubulopathy in diabetic nephropathy among children with normoalbuminuria.
Hafez MH; El-Mougy FA; Makar SH; Abd El Shaheed S
Iran J Kidney Dis; 2015 Mar; 9(2):126-31. PubMed ID: 25851291
[TBL] [Abstract][Full Text] [Related]
4. Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration.
Fu WJ; Li BL; Wang SB; Chen ML; Deng RT; Ye CQ; Liu L; Fang AJ; Xiong SL; Wen S; Tang HH; Chen ZX; Huang ZH; Peng LF; Zheng L; Wang Q
Diabetes Res Clin Pract; 2012 Jan; 95(1):105-9. PubMed ID: 22015481
[TBL] [Abstract][Full Text] [Related]
5. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
[TBL] [Abstract][Full Text] [Related]
6. Changes of serum and urine neutrophil gelatinase-associated lipocalin in type-2 diabetic patients with nephropathy: one year observational follow-up study.
Yang YH; He XJ; Chen SR; Wang L; Li EM; Xu LY
Endocrine; 2009 Aug; 36(1):45-51. PubMed ID: 19390997
[TBL] [Abstract][Full Text] [Related]
7. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK
Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril.
Nielsen SE; Schjoedt KJ; Astrup AS; Tarnow L; Lajer M; Hansen PR; Parving HH; Rossing P
Diabet Med; 2010 Oct; 27(10):1144-50. PubMed ID: 20854382
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease.
Bolignano D; Lacquaniti A; Coppolino G; Campo S; Arena A; Buemi M
Kidney Blood Press Res; 2008; 31(4):255-8. PubMed ID: 18600028
[TBL] [Abstract][Full Text] [Related]
10. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
Rhee H; Shin N; Shin MJ; Yang BY; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY
Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
[TBL] [Abstract][Full Text] [Related]
11. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
Wu C; Wang Q; Lv C; Qin N; Lei S; Yuan Q; Wang G
Diabetes Res Clin Pract; 2014 Nov; 106(2):343-50. PubMed ID: 25263500
[TBL] [Abstract][Full Text] [Related]
12. Urinary neutrophil gelatinase-associated lipocalin and progression of diabetic nephropathy in type 1 diabetic patients in a four-year follow-up study.
Nielsen SE; Hansen HP; Jensen BR; Parving HH; Rossing P
Nephron Clin Pract; 2011; 118(2):c130-5. PubMed ID: 21160226
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil gelatinase associated lipocalin as an indicator of acute kidney injury and inflammation in burned children.
Yavuz S; Anarat A; Acartürk S; Dalay AC; Kesiktaş E; Yavuz M; Acartürk TO
Burns; 2014 Jun; 40(4):648-54. PubMed ID: 24060429
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of neutrophil gelatinase-associated lipocalin in normoalbuminuric normotensive type 1 diabetic adolescents.
Demir K; Abaci A; Küme T; Altincik A; Catli G; Böber E
J Pediatr Endocrinol Metab; 2012; 25(5-6):517-23. PubMed ID: 22876548
[TBL] [Abstract][Full Text] [Related]
15. Do neutrophil gelatinase-associated lipocalin and interleukin-18 predict renal dysfunction in patients with familial Mediterranean fever and amyloidosis?
Deveci K; Korkmaz S; Senel S; Deveci H; Sancakdar E; Uslu AU; Deniz A; Alkan F; Seker MM; Sencan M
Ren Fail; 2014 Apr; 36(3):339-44. PubMed ID: 24320110
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease.
Bolignano D; Coppolino G; Campo S; Aloisi C; Nicocia G; Frisina N; Buemi M
Am J Nephrol; 2007; 27(4):373-8. PubMed ID: 17570904
[TBL] [Abstract][Full Text] [Related]
17. Clinical value of NGAL, L-FABP and albuminuria in predicting GFR decline in type 2 diabetes mellitus patients.
Chou KM; Lee CC; Chen CH; Sun CY
PLoS One; 2013; 8(1):e54863. PubMed ID: 23349979
[TBL] [Abstract][Full Text] [Related]
18. [NGAL: a biomarker of acute and chronic renal dysfunction].
Lalanne A; Beaudeux JL; Bernard MA
Ann Biol Clin (Paris); 2011; 69(6):629-36. PubMed ID: 22123561
[TBL] [Abstract][Full Text] [Related]
19. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.
Fu WJ; Xiong SL; Fang YG; Wen S; Chen ML; Deng RT; Zheng L; Wang SB; Pen LF; Wang Q
Endocrine; 2012 Feb; 41(1):82-8. PubMed ID: 21779943
[TBL] [Abstract][Full Text] [Related]
20. Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.
Xiang D; Zhang H; Bai J; Ma J; Li M; Gao J; Wang C
Int J Clin Exp Pathol; 2014; 7(10):7172-81. PubMed ID: 25400814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
